Grace Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Aug 11, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 25, 2025 · D | Aug 11, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $30,000,203 | $9,999,998 | $-20,000,205 |
| Reported amount sold | $14,999,985 | $9,999,998 | $-4,999,987 |
| Reported investor count | — | 9 | — |
| Reported minimum investment | $1 | $1 | $0 |
Earlier SEC source: 0001140361-25-005827 · Later SEC source: 0001123292-26-001084
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $9,999,998
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $9,999,998
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Blaize Holdings, Inc. · CIK 1871638
- DealerCue Automotive Corp. · CIK 1979783
- Verrica Pharmaceuticals Inc. · CIK 1660334
Form D filings (2)
-
0001123292-26-001084D · Aug 11, 2026 · PharmaceuticalsOffering: $9,999,998Sold: $9,999,998
Compared with 0001140361-25-005827:
- Reported offering amount: $30,000,203 → $9,999,998
- Reported amount sold: $14,999,985 → $9,999,998
- Reported investor count: Unavailable → 9
-
0001140361-25-005827D · Feb 25, 2025 · BiotechnologyOffering: $30,000,203Sold: $14,999,985